Back to Newsroom

Sigilon Therapeutics to Present at the 2017 Biotech and Money Inv€$tival Showcase Conference in London

CAMBRIDGE, Mass.Nov. 10, 2017 /PRNewswire/ — Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced that Devyn Smith, Ph.D., Sigilon Therapeutics Chief Strategy Officer and Head of Operations, will present at the upcoming 2017 Biotech and Money Inv€$tival Showcase, organized in partnership with Jefferies LLC, and attend the Jefferies 2017 London Healthcare Conference taking place Nov. 15-16, 2017. Details are as follows:


Tuesday, Nov. 14, 2017


11:45 a.m. GMT


The Hilton Waldorf Hotel, London

Read More Here